Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Li H et al. | Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. | 2012 | Diabetes | pmid:22338096 |
Wang C et al. | Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. | 2012 | Diabetes Metab. Res. Rev. | pmid:22228707 |
Wang JP et al. | Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression. | 2011 | Differentiation | pmid:21074928 |
Smardová J et al. | CBP sensitizes v-myb-transformed monoblasts to differentiation inducers. | 2005 | Differentiation | pmid:16026544 |
Turovets N et al. | Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin A pretreatment. | 2011 | Differentiation | pmid:21306817 |
El-Serafi AT et al. | Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. | 2011 | Differentiation | pmid:20970916 |
Murko C et al. | Histone deacetylase inhibitor Trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube. | 2013 | Differentiation | pmid:23328540 |
Nishida N et al. | Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmasking. | 2014 | Dig Dis | pmid:25376292 |
Hartman H et al. | Histone deacetylase regulates trypsin activation, inflammation, and tissue damage in acute pancreatitis in mice. | 2015 | Dig. Dis. Sci. | pmid:25492506 |
Chang X et al. | DNA methylation of NDRG2 in gastric cancer and its clinical significance. | 2013 | Dig. Dis. Sci. | pmid:23010743 |
Jackson K et al. | Epigenetic silencing of somatostatin in gastric cancer. | 2011 | Dig. Dis. Sci. | pmid:20927589 |
Kawamura T et al. | Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts. | 2009 | Dig. Dis. Sci. | pmid:18629644 |
Meng Y et al. | Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma. | 2011 | Dig. Dis. Sci. | pmid:21567192 |
Matsusue K et al. | Characterization of mouse metastasis-associated gene 2: genomic structure, nuclear localization signal, and alternative potentials as transcriptional activator and repressor. | 2001 | DNA Cell Biol. | pmid:11749719 |
Garcia-Villalba P et al. | Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression. | 1997 | DNA Cell Biol. | pmid:9150429 |
Veilleux S and Boissonneault G | Dynamics of reporter gene stimulation by HMG box proteins. | 2002 | DNA Cell Biol. | pmid:12015897 |
Duo J et al. | Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. | 2013 | DNA Cell Biol. | pmid:23451817 |
Varol N et al. | The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24). | 2014 | DNA Cell Biol. | pmid:24665856 |
Blais M et al. | Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter. | 2005 | DNA Cell Biol. | pmid:15812237 |
Skoge RH et al. | Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels. | 2014 | DNA Repair (Amst.) | pmid:24814981 |
KraevskiÄ VA and Prasolov VS | [Comparative analysis of higher levels of organization of normal and hyperacetylated chromatin]. | 1999 | Dokl. Akad. Nauk. | pmid:10439916 |
Foubister V | Anticancer drug shows promise against lupus. | 2003 | Drug Discov. Today | pmid:12681930 |
Elaut G et al. | Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes. | 2002 | Drug Metab. Dispos. | pmid:12433798 |
Paterson S et al. | Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells. | 2011 | Drug Metab. Dispos. | pmid:20870783 |
Sanderson L et al. | Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice. | 2004 | Drug Metab. Dispos. | pmid:15269190 |
Cecconi D et al. | Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. | 2003 | Electrophoresis | pmid:12783462 |
Williams SA et al. | NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. | 2006 | EMBO J. | pmid:16319923 |
Murphy JC et al. | Control of cytomegalovirus lytic gene expression by histone acetylation. | 2002 | EMBO J. | pmid:11867539 |
Krämer OH et al. | The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. | 2003 | EMBO J. | pmid:12840003 |
Kasper LH et al. | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 2005 | EMBO J. | pmid:16237459 |
Nielsen AL et al. | Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. | 1999 | EMBO J. | pmid:10562550 |
Jordan A et al. | The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. | 2001 | EMBO J. | pmid:11285236 |
Van Lint C et al. | Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. | 1996 | EMBO J. | pmid:8605881 |
Wong J et al. | Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. | 1998 | EMBO J. | pmid:9430643 |
Clayton AL et al. | Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. | 2000 | EMBO J. | pmid:10899125 |
O'Neill LP et al. | A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation. | 1999 | EMBO J. | pmid:10329635 |
O'Neill LP and Turner BM | Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. | 1995 | EMBO J. | pmid:7664735 |
Schmittwolf C et al. | In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. | 2005 | EMBO J. | pmid:15660132 |
Ciana P et al. | Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. | 1998 | EMBO J. | pmid:9857194 |
Méndez-Pertuz M et al. | The thyroid hormone receptor antagonizes CREB-mediated transcription. | 2003 | EMBO J. | pmid:12805224 |
Criqui-Filipe P et al. | Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. | 1999 | EMBO J. | pmid:10369679 |
Craig JM et al. | Centromeric chromatin pliability and memory at a human neocentromere. | 2003 | EMBO J. | pmid:12743043 |
Muth V et al. | Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. | 2001 | EMBO J. | pmid:11250901 |
Gay S et al. | Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions. | 2010 | EMBO Rep. | pmid:20671737 |
Taddei A et al. | The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? | 2005 | EMBO Rep. | pmid:15940285 |
Oride A et al. | Trichostatin A specifically stimulates gonadotropin FSHβ gene expression in gonadotroph LβT2 cells. | 2014 | Endocr. J. | pmid:24430728 |
Nakada Y et al. | Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells. | 2015 | Endocr. J. | pmid:26497760 |
Pianta A et al. | Nucleophosmin delocalization in thyroid tumour cells. | 2011 | Endocr. Pathol. | pmid:21258971 |
Baradari V et al. | Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. | 2006 | Endocr. Relat. Cancer | pmid:17158768 |
Kogai T et al. | Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. | 2006 | Endocr. Relat. Cancer | pmid:16954431 |